header logo image


Page 656«..1020..655656657658..670680..»

Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabet | PPA – Dove Medical Press

March 3rd, 2020 1:44 pm

Ewelina Bk,1 Ewa Marcisz-Dyla,2 Agnieszka Mynarska,3 Danuta Sternal,1 Monika Kadubowska,1 Czesaw Marcisz3

1Faculty of Health Sciences, University of Bielsko-Biala, Bielsko-Biala, Poland; 2Department of Anxiety Disorders, Hospital of Ministry of Internal Affairs, Katowice, Poland; 3Department of Gerontology and Geriatric Nursing, School of Health Sciences, Medical University of Silesia, Katowice, Poland

Correspondence: Ewelina BkFaculty of Health Sciences, University of Bielsko-Biala, ul. Willowa 2, Bielsko-Biala 43-309, PolandTel +48 33 827 9198Email ewelina.bak76@wp.pl

Purpose: Patients with diabetes are at increased risk of developing depression. The aim of the study was to determine the occurrence of depressive symptoms in patients with type 1 (T1DM) and type 2 diabetes (T2DM), including the association with different independent sociodemographic and clinical variables.Patients and Methods: The studies were carried out on 618 people, including 115 patients with T1DM and 215 patients with T2DM and 288 people without diabetes constituting two control groups. Subjects were characterized in terms of sociodemographic, clinical and biochemical aspects, and the occurrence of depressive symptoms using Beck Depression Inventory (BDI) was determined. In the logistic regression analysis, the correlations between BDI score and with independent variables such as sex, age, body mass index, duration of diabetes, HbA1c level, diabetic complications and mean arterial pressure were examined.Results: The mean BDI score was significantly higher in women and men with T1DM and T2DM compared to controls. In diabetic patients, depressive symptoms occurred more often in women than in men. Among patients with T1DM, the incidence of depressive symptoms was 17.5% of the women and 8.6% of the men and in patients with T2DM, the incidence ofdepressive symptoms was revealed in 28.9% of the women and in 19.8% of the men. In patients with T1DM and T2DM, the occurrence of depressive symptoms increases with age, HbA1c level and complications, and the risk of depressive symptoms turned out to be almost three times higher in women than in men with T2DM.Conclusion: The prevalence of depressive symptoms in diabetic patients is higher than in non-diabetics. Depressive symptoms account for 13% of the patients with T1DM and 24.7% of the patients with T2DM. The risk of depressive symptoms in T1DM and T2DM increases with age, HbA1c level and the presence of complications, and it is gender-related in T2DM only.

Keywords: type 1 diabetes, type 2 diabetes, depressive symptoms, Beck Depression Inventory

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

See more here:
Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabet | PPA - Dove Medical Press

Read More...

Diabetes customers should not eat this thing – Sahiwal Tv

March 3rd, 2020 1:44 pm

A lengthy record is directed at diabetics in other words. in order to prevent diabetes customers. This is simply because the sugar amount in diabetes begins to be high, it is therefore better to keep away from such foods that have even more volume.

Should not consume this thing:

# Beans: Beans may possibly not be nice but they are saturated in starch.

->In this situation, and even though this green veggie is here, it must be averted as a result of extra starch. If you prefer beans, you can easily boil it and eat it.

# Potato or sweet-potato: Potato and sankarakandi are packed with starch and sweetness. Diabetes customers should prevent consuming this too. Boiled may be consumed sometimes.

# Pumpkin: Pumpkin can be really nice. Green pumpkin is consumed sometimes. By steering clear of these veggies, you are able to help keep your self far from dangerous conditions brought on by diabetes.

# Beetroot: It contains much more sweetness. It isnt that you simply cant consume beet after all, but its volume can be extremely tiny or as soon as in per week.

Link:
Diabetes customers should not eat this thing - Sahiwal Tv

Read More...

eKare joins the NIH-led Diabetic Foot Consortium for Landmark Diabetic Foot Ulcer Research – PR Web

March 3rd, 2020 1:44 pm

eKares inSight 3D wound management platform

FAIRFAX, Va. (PRWEB) March 03, 2020

eKare has been selected after an open competition to join the prestigious Diabetic Foot Consortium (DFC) organized by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a branch of the National Institute of Health (NIH). The objective of the DFC is to establish an organizational framework at the national level to facilitate integrated clinical and translational research to improve outcomes for patients with diabetic foot ulcers (DFUs).

DFUs represent a significant quality of life issue for patients and cost about $13 billion nationally.(1) The DFC is prioritizing DFU research and accelerating the development and validation of wound biomarkers to improve prediction of outcomes. The consortium includes:

eKares inSight, a comprehensive 3D wound management system, will be uniformly utilized across the institutions for standardized data collection and monitoring of wound progression.

An initiative of such breadth and rigor dedicated to diabetic foot ulcer research is unprecedented, says Patrick Cheng, CEO of eKare. eKare is honored to have been selected by NIDDK and join the Diabetic Foot Consortium to help spearhead breakthrough advancements in DFU research.

About eKareeKare Inc. is dedicated to the design and development of wound assessment solutions, including 3D wound dimensions and tissue classification capabilities, using the latest computer-vision and mobile technology. eKare's innovative technology is creating new possibilities in how we deliver wound care across the healthcare continuum, from inpatient hospital and skilled nursing facilities to ambulatory clinics and telemedicine. eKare's mission is to advance the science and delivery of wound care by leveraging mobile and sensor technologies to connect patients, providers, and industry.

The content in this release is the sole responsibility of the authors and does not necessarily represent the official views or imply endorsement of the National Institutes of Health.

1. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):2931. doi:10.1177/2042018817744513.

Share article on social media or email:

Go here to see the original:
eKare joins the NIH-led Diabetic Foot Consortium for Landmark Diabetic Foot Ulcer Research - PR Web

Read More...

Story of Theresa’s ‘Schule Bell’ to be recognized by historic marker – NNY360

March 3rd, 2020 1:44 pm

THERESA The story of Schule Bell will ring with greater prominence here when a historical marker is placed in the spring, thanks to a private grant-making foundation based in Syracuse.

In April of 1865 in the final days of the Civil War, legend has it, a train brought yet another coffin to Philadelphia, destination Theresa, which didnt have railroad service yet. The box was removed from one of the trains cars by an honor guard. The coffin was then put on a horse-drawn wagon for its next destination. But it wasnt to a graveyard. Those receiving the container had no intention of burying what was inside.

Out of sight of the military escort, those receiving the coffin finally pried it open. Inside, as anticipated, was a bell for the new Theresa schule, courtesy of Union soldiers conspiracy against a Confederate locomotive, from which the bell was taken. The bells clapper had been removed and cushioned, while a large log gave the coffin the weight of a body.

The bell heist had its roots when at least one of the soldiers learned that a school about to open in his home town of Theresa needed a bell for its new schoolhouse.

The story, as retold in the 1992 book Whispers From the Past by Harold I. Sanderson, a local historian who died in 2013, had its roots in Petersburg, Va. Union soldiers were aware of a train engine that had become partially submerged in the James River after Union forces destroyed a section of railroad. An 80-pound bronze bell mounted on the locomotive should toll well for the new school back home, one of them thought. So the trio snatched their trophy from the disabled train. One of the three, a morticians assistant, thought upon the idea of sending the bell home in a coffin.

According to the Times files, the bell was taken from the locomotive by Otis Brooks, a soldier from Theresa who was also a contractor in town. He sold the bell to the Theresa School District for $50. A 1938 Times report on the bell said it had been in use for the past 69 years from 1869, when the school opened. The bell has been housed in the Theresa Primary School (formerly Theresa High School) since 1938.

A 1935 Watertown Daily Times story noted a less glamorous story on the origin of the bell, but with just a few details:

A soldier from Theresa walked out on the southern engine (of the swamped train) and succeeded in removing the bell and making it his property. By carefully boxing the bell in other articles and marking it personal, he managed to ship it north to Theresa.

The town of Theresa has received a grant from the Pomeroy Foundation to obtain a roadside marker that will feature the basics of the Schule Bell legend. The marker, now in production, is part of the foundations Legends & Lore marker grant program. The Pomeroy Foundation, which helps people celebrate their communitys history, provides grants that cover the entire cost of a marker, pole and shipping.

The marker is a milestone for the foundation. Its the 1,000th sign it has created.

It will be installed near a Civil War monument in the towns Oakwood Cemetery. That monument, on a rise of ground not far from the cemeterys entrance off Cemetery Road, was gifted by local Civil War veteran August Kissell and dedicated in May of 1911.

At one time, there apparently was a small monument noting the Schule Belle at Oakwood Cemetery. It has since disappeared.

Ive gone through Oakwood Cemetery with a fine-tooth comb, but I cant find it, said Timothy S. Minnick, Town of Theresa Historian.

Plans are underway for a Schule Bell Legends & Lore marker dedication.

If nature cooperates, wed love to have it Memorial Day weekend, said Mr. Minnick, of Syracuse. Were not going to know until I get up there and start leveling stones around the marker and theres a little bit of cement work underneath that the town needs to patch up. Theyre going to get to that as soon as it gets warm enough.

Mr. Minnick said that once installed, the monument will add to the Civil War lore that can be found in Theresa.

We have a lot of artifacts in the Theresa Free Library from the Civil War, Mr. Minnick said. Theres a drum, muskets, pictures and swords. Civil War is big on tourism. People dont have to travel to Gettysburg to get a taste of the Civil War. Thats what we would like to do.

In addition to the war monument at Oakwood Cemetery, theres one at the intersection of Main Street and Riverside Avenue in Theresa featuring a 15-foot Civil War soldier. The site also includes a cannon and the location also honors veterans of the Spanish-American War of 1898.

Funding our 1,000th marker is an exciting moment, especially as we celebrate the foundations 15th anniversary this year, Deryn Pomeroy, trustee and director of Strategic Initiatives for the Pomeroy Foundation said in a news release.

Ms. Pomeroy said the foundation has seen firsthand the benefits and impact its markers have on communities.

Markers help preserve history, educate the public, encourage pride of place and enhance historic tourism, she said. We are proud to support the town of Theresa and all those over the years who have done great work to recognize their history or folklore through our marker programs.

Mr. Minnick said the marker for the Schule Bell will inform generations of people for years.

With the transient nature of the north country and Fort Drum people not having roots, these stories are going to die unless we keep them alive, he said. Thats where I really appreciate the Pomeroy Foundation because Ive heard the legend of the bell since I was a kid, but I bet I probably havent heard it in 15 years. Now, people will know it, long after were dead.

New York Folklore is the Pomeroy Foundations Legends & Lore partner in New York State and originally helped to found the program in 2015.

The Schule Bell story of how some creative individuals hoodwinked Confederate troops and shipped a heavy bell to Northern New York, falls into the classic trickster type of story in which wits and guile are used to effect a good outcome, Ellen McHale, New York Folklores executive director said in a news release. The Schule Bell story is just one example of the many important pieces of local lore and history often known only within a specific locale. The Legends & Lore marker program provides a wonderful opportunity for communities to share those types of unique stories to reach a wider public audience.

Among the missions of the William G. Pomeroy Foundation is supporting the celebration and preservation of community history. It also has a mission to raise awareness, support research and to improve the quality of care for patients and their families who are facing a blood cancer diagnosis.

After beating acute myeloid leukemia in 2005 with a stem cell transplant, William G. Pomeroy established the foundation. In 2006, it launched its first program, the New York State Historic Marker Grant Program, commemorating historic people, places and things.

The 40-pound markers, 18-inches-by-32-inches, manufactured by the foundry Sewah Studios, Marietta, Ohio, cost $1,100 and are shipped by UPS with aluminum 7-foot poles. The foundation has six marker programs.

Lowes Home Improvement in Watertown, donated materials (landscaping stones, mulch, soil, flag and flag pole) to help beautify the area around the monument and marker at Oakwood Cemetery.

The new marker will be located in the shadow of the zinc 16-foot monument dedicated in 1911 and funded by August Kissell (1842-1923). The native of Germany sailed for America at the age of 15 and settled with family in Theresa. In the Civil War, he was a member of the 94th New York Volunteer Infantry regiment and fought in several battles before becoming a prisoner of war in Salisbury, N.C. He managed to escape from the Confederate POW camp in January of 1865 and made his way to Union lines at Knoxville, Tenn. After the war, he became a dealer in monuments.

His grave site is also near the soldiers and sailors monument he gifted in 1911. Among the many features of the monument is a base-relief figure of Abraham Lincoln.

At the monuments dedication ceremony in 1911, according to Times files, Mr. Kissell told the crowd:

I am glad to be with you here today. I am glad I was able to erect this monument in honor of our services and those of our companions who have gone before us; and I can only say that it is the greatest pleasure that I have, on seeing that monument, that it will bear our names and carry our memories as long as this government shall stand, which I hope will be forever.

Also speaking that day was New York State Senator George H. Cobb.

How poor this world would be without its graves, without the memories of its mighty dead, Mr. Cobb said. Only the voiceless speak forever.

Read the original here:
Story of Theresa's 'Schule Bell' to be recognized by historic marker - NNY360

Read More...

4 ways to soak up the Cape Town summer – IOL

March 3rd, 2020 1:44 pm

By Staff Reporter Feb 28, 2020

Share this article:

Cape Towns weather is fabulous this time of year with sunny days on the horizon until the colder weather creeps in a few months. Briony Brookes, the Communications and PR Manager of Cape Town Tourism, shares how travellers can enjoy in Cape Town on a warm summers day:

Watch the sunrise from Lions Head and sunset from Signal Hill

Sunrise is beautiful anywhere in the world, but a sunrise from Lion's Head is one of those rare uplifting sights that you have to see once. When hiking up before the crack of dawn, youll be rewarded with 360 views of Cape Town.Signal Hill, with its striking views of the city, the ocean and the mountains, is an incredible spot for watching the sunset in the Mother City. Arrive early to secure a good spot before it gets overcrowded.

Chapmans Peak Drive

With the expansive Atlantic Ocean on one side and the beautiful views of the Constantiaberg Mountain on the other, Chapmans Peak Drive is ideal for a lovely sunset car drive with your loved ones. There are also look-out spots and over 50 picnic spots along the road. So, pack some snacks and take in everything Chapmans Peak has to offer.

Go all the way to the tip of the African continent

No Cape Town itinerary is complete without a trip to Cape Point. Many tourists and locals are under the impression that the only thing worth seeing at the Reserve are the Lighthouses. They couldnt be more mistaken. There are plenty of things to do at Cape Point, whether its going on a hike or taking a ride on the Flying Dutchman Funicular (the only one of its kind on the African continent.) The Reserve also has a secret beach which is just waiting to be discovered, although swimming isnt allowed there owing to the strong currents. Locals also qualify for a discount at Cape Point when bringing along their IDs.

Take a stroll through the art-filled streets of Woodstock

Woodstock has the best street art in Cape Town. Over 100 works of colourful street art adorn the corners and streets of this bustling neighbourhood. One could easily spend a couple of hours just roaming the streets and admiring this vibrant area. There are also guided walks available which allow you to meet the artists behind the art and discuss the meaning of some of the images.

More here:
4 ways to soak up the Cape Town summer - IOL

Read More...

Stem Cell Therapy for Knees: Process, Efficacy, and Cost

March 3rd, 2020 1:42 pm

Throughout the United States, stem cell therapy is being touted as a miracle cure for everything from wrinkles to spinal repair.

Though very few of these applications have any scientific backing, stem cell therapy for knees has been the subject of quite a few promising studies.

Arthritis develops when the cartilage lining the joints starts to deteriorate, causing pain and limiting function. Osteoarthritis is incredibly common. Arthritis and similar conditions are a major cause of disability in the United States.

Every year about 600,000 Americans get a knee replacement, a number that could rise to 3 million by 2030. Until recently, treatment options were either temporary or surgical.

Now, in numerous cases, stem cell therapy for knees is reducing pain and repairing cartilage. As a result, many people have been able to improve their quality of life and avoid surgery.

As studies continue, the forms and combinations of stem cell preparations are improving, and outcomes are expected to improve as well.

The job of adult stem cells is to maintain and heal tissues by replenishing damaged and dying cells. In some areas of the body, such as the knee, blood supply is limited, so stem cells dont work as well as they should.

Alternatively, though, they can be injected, at which point they appear to initiate the self-recovery process.

The usual job of joint cartilage is to promote smooth movement of joint surfaces and protect bones from friction. This process allows for shock absorption of up to 20 times the weight of the body. Its essential to physical movement, especially in athletics.

Osteoarthritis is one of the most common chronic degenerative disorders and it very often affects the knee, causing deterioration of its joint cartilage over time.

Osteoarthritis can also begin as a result of a knee injury, such as a ligament tear, tendon damage, or a fracture.

In the face of damage, the joint becomes unstable and this wears down the articular cartilage. From there, the bone can suffer damage as well, in addition to the synovial joint lining, tendons, ligaments, and muscles.

Stem cell therapy for knees is minimally invasive. Its a procedure that can decrease inflammation, slow and repair all these forms of damage from arthritis, and delay or prevent knee replacement surgery.

Adult stem cells can be extracted from bone marrow or fat through simple methods. Its then concentrated and injected into the knee with image guidance, usually to successful results.

In one study, patients experienced improvement in both knees even though only one knee was injected. Although natural deterioration of the knee continues, at five years, those knees that are injected with stem cells are in better shape than they were before the injections.

Researchers believe that stem cell therapy for the knee works by:

Ongoing research is striving to determine which stem cell knee therapy techniques, cell choices, and dosages yield the most effective and consistent results.

While some seem more potent than others and overall results are promising, more research is needed.

Stem cell treatment for knees is noninvasive and rarely painful. Side effects are minimal.

The most frequent experiences after the procedure include mild pain at the injection site, swelling, and some joint stiffness.

A review of multiple medical institutions reveals an average cost for stem cell treatment for knees of approximately $3,000 to $5,000 per knee, depending largely on geographical location.

Most insurance companies dont cover stem cell injections yet, but that may be starting to change as more research accumulates showing the effectiveness of the process.

People typically complete the procedure in one visit, but usually have an initial consultation and a follow-up appointment. The injections take approximately two to three hours.

Although stem cell therapy can pose serious risks when performed on other parts of the body, such as the eyes or the spine, its relatively safe when performed on the knees.

Stem cell therapy using adult stem cells is safest because the stem cells are collected from the persons own body. This reduces the risk of a bad reaction.

Risks are increased if:

Because this is such a new area, new research is released frequently.

While the FDA is closely watching stem cell therapy developments, the only applications that are approved involve embryonic stem cells to treat blood or immune system disorders.

If youre experiencing knee pain or limited knee mobility, alternative initial treatments might include anti-inflammatory medications, opioid pain medications, or physical therapy.

Alternative treatments include injections with platelet-rich plasma, hyaluronic acid, or steroids.

Surgical treatments may be tried as well, such as arthroscopy, subchondral bone drilling, or microfracture.

Stem cell therapy for knees is still very new and the FDA is proceeding with caution, but studies so far are very promising.

Many people have successfully avoided knee surgery and side effects are minimal for this particular body part.

Follow this link:
Stem Cell Therapy for Knees: Process, Efficacy, and Cost

Read More...

10 things to know about stem cell therapy – Outlook India

March 3rd, 2020 1:42 pm

10 things to know about stem cell therapy

New Delhi, March 3 (IANSlife) The usage of stem cells to cure or treat a disease or repair the injured tissue is defined as stem cell therapy. The best example of the stem cell treatment is seen in patients suffering from restoring the vision of the damaged eyes, grafting of the skin in severe burnt conditions. Stem cell treatments for brain or neural diseases like Parkinson''s and Alzheimer''s disease, multiple sclerosis, preventing heart strokes, curing diabetes, kidney disorders, autism, and spinal cord injuries are progressively making their way. Vipul Jain, CEO of Advancells and also a Serial entrepreneur, explains in detail the treatment, its uses, cost and effectiveness.

Q: What are stem cells?

Undifferentiated cells that are able to differentiate and transform into any type of cells of the body when and where needed. They have an enormous potential to repair, heal and regenerate. Stem cells come from blood, bone marrow, umbilical cord blood and adipose tissue.

Types of stem cell therapy

Autologous stem cell therapy: Patient receives stem cells from his/her own body

Allogeneic stem cell therapy: Patient receives the stem cells donated by another individual

Autologous stem cell therapy is better than allogeneic stem cell therapy as chances of mismatching are not there and they pose the minimum risk of immune rejection. Also, no side effects or adverse effects are seen as a person''s own blood cells are used. They start the healing process immediately in a natural way.

What is stem cell therapy?

The usage of stem cells to cure or treat a disease or repair the injured tissue is defined as stem cell therapy. Stem cells can be obtained from the bone marrow, adipose tissues etc. Due to their tremendous potential to prevent and to treat various health conditions and to repair the injured tissues global research investigation is continuously being done as to explore the maximum advantage of these cell lines.

The best example of the stem cell treatment is seen in patients suffering from restoring the vision of the damaged eyes, grafting of the skin in severe burnt conditions. Stem cell treatments for brain or neural diseases like Parkinson''s and Alzheimer''s disease, multiple sclerosis, preventing heart strokes, curing diabetes, kidney disorders, autism, and spinal cord injuries are progressively making their way.

What are the sources of stem cell?

Depending upon the disease, different stem cell source can be used in a specific condition. The procedure may involve the extraction of stem cells from adipose tissue-derived stem cells with the combination of PRP (Platelet-rich plasma) or can be obtained from bone marrow that can differentiate into progenitor cells that differentiate into various other tissues which can help in the therapy.

Procedure of stem cell therapy

The stem cells are isolated from the bone marrow or adipose tissues followed by their processing and enrichment under sterile conditions. These activated stem cells are placed back into the patient''s body at the target site for repairing the damaged tissue. It is necessary that the stem cells are injected in the specific area of injury as only then the desired results will be achieved.

Adipose stem cells are preferred over bone marrow stem cells as they are easy to isolate and contain a higher number of stem cells.

Stem cells injection

The stem cells injections are gaining much interest because it is devoid of the painful procedure, takes less time in comparison to a surgery, there are no host and recipient rejections as stem cells are harvested from the patient''s body itself and a targeted delivery system is available.

The stem cells obtained are processed in a sophisticated stem cell lab and after activation are inserted back into the host with the help of intravenous, intramuscular, intra-arterial, intradermal and intrathecal injections as per the requirement of the treatment process.

What is the use of anesthetics and why? Usually, local anesthetics are used during a stem cell procedure to numb the area but sometimes general anesthesia is also given while extracting the stem cells from bone marrow. But it is necessary to find out what anesthetic your doctor uses during orthopedic stem cell treatments.

A number of anesthetics have been found to kill the stem cells thus; the treatment''s end result will greatly depend on the use of anesthetics. Some anesthetics very well sync with the stem cell and hence, aid in the treatment.

How good are the processing techniques in the onsite labs?

Stem cells are to be extracted and processed in a clean room, under aseptic conditions maintaining a controlled environment. The doctor should explain the entire process and the number of viable stem cells infused into the patient during the process. Also, the precision of the injections to provide good quality of stem cells at the site of injury will help in better and faster recovery of the patient''s damaged area.

Duration and cost of the therapy

Cost of the treatment and its duration varies from one patient to another. The disease which needs to be cured, the severity, age factor, health condition, etc, define the duration of the therapy. One may respond during the treatment phase itself while the other may show results after a few sessions or weeks. Depending upon the disease diagnosed, the stem cells extracted, duration of the therapy, other adjuvants used in the process, the cost of the stem cell therapy can vary.

Follow-up visits

It is essential that after the stem cell therapy the patient should visit the stem cell doctor for recuperation therapies. The primary goals of such therapy is the prevention of secondary complications, analysis of recovery of motor, sensory and all the bodily functioning, psychological support/counseling for depression, mood swings or anxiety etc. and reintegration into the community.

There can be different sets of precautions which need to be followed at various steps for the recovery of the damaged tissues. The treatment and post treatment conditions may vary from person to person depending upon the disease and the severity.

Success rate of stem cell therapy

Stem cell therapy has shown results in treating serious ailments like leukemia, grafting tissues, autism, orthopedic conditions and skin problems etc. Stem Cell Therapy has been successfully used in the treatment of around 80 serious disorders.

Survival rates among patients who received stem cell treatment are significantly high, whether the cell donors are related or unrelated to them. With the ongoing research around the world, scientists are exploring new possibilities in which a number of life threatening diseases can be prevented and cured hence, the stem cells have proved to be promising in the near future as many aspects are yet to be revealed.

--IANS

pg/adr/

Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: IANS

Link:
10 things to know about stem cell therapy - Outlook India

Read More...

Stem Cell Therapy Market 2020 Analysis by Overview, Growth, Top Companies, Trends, Demand and Forecast to 2026 – Packaging News 24

March 3rd, 2020 1:42 pm

Verified Market Research adds new research report on market size for Stem Cell Therapy and regional forecasts for 2020-2026. The report provides an in-depth analysis of the Stem Cell Therapy market, taking into account market dynamics, segmentation, geographic expansion, the competitive landscape, and various other key issues. The market analysts who prepared the report have thoroughly examined the Stem Cell Therapy market and provided reliable and accurate data. They understand the needs of the industry and customers, so they can easily focus on the issues that end users have been looking for. The research report provides an analysis of an assessment of existing and upcoming trends in which players can invest. It also includes an assessment of the players financial prospects and the nature of the competition.

Global Stem Cell TherapyMarketwas valued at USD 86.62 million in 2016 and is projected to reach USD 221.03million by 2025, growing at a CAGR of 10.97% from 2017 to 2025.

This report includes the following Companies; We can also add other companies you want:

Stem Cell Therapy Market: Competitive Landscape

The competitive landscape is a must for market participants to withstand the competition in the Stem Cell Therapy market. This helps market participants to develop effective strategies to optimize their market positions. In addition, the competitive analysis helps them identify potential benefits and obstacles in the Stem Cell Therapy market. This allows them to monitor how their competitors are implementing different strategies, including pricing, marketing, and sales.

Stem Cell Therapy Market: Drivers and Limitations

The report section explains the various drivers and controls that have shaped the global market. The detailed analysis of many market drivers enables readers to get a clear overview of the market, including the market environment, government policy, product innovation, development and market risks.

The research report also identifies the creative opportunities, challenges, and challenges of the Stem Cell Therapy market. The framework of the information will help the reader identify and plan strategies for the potential. Our obstacles, challenges and market challenges also help readers understand how the company can prevent this.

Stem Cell Therapy Market: Segment Analysis

The report section contains segmentations such as application, product type and end user. These segments help determine which parts of the market will improve over others. This section analysis provides information on the most important aspects of developing certain categories better than others. It helps readers understand strategies to make solid investments. The market for Stem Cell Therapy is segmented according to product type, applications and end users.

Stem Cell Therapy Market: Regional Analysis

This section of the report contains detailed information on the market in different regions. Each region offers a different market size because each state has different government policies and other factors. The regions included in the report are North America, Europe, Asia Pacific, the Middle East and Africa. Information about the different regions helps the reader to better understand the global market.

Ask for Discount @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=PN24&utm_medium=001

Table of Content

1 Introduction of Stem Cell Therapy Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Stem Cell Therapy Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Stem Cell Therapy Market , By Deployment Model

5.1 Overview

6 Stem Cell Therapy Market , By Solution

6.1 Overview

7 Stem Cell Therapy Market , By Vertical

7.1 Overview

8 Stem Cell Therapy Market , By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Stem Cell Therapy Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Request Report Customization @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=PN24&utm_medium=001

About Us:

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

TAGS: Stem Cell Therapy Market Size, Stem Cell Therapy Market Growth, Stem Cell Therapy Market Forecast, Stem Cell Therapy Market Analysis, Stem Cell Therapy Market Trends, Stem Cell Therapy Market

Excerpt from:
Stem Cell Therapy Market 2020 Analysis by Overview, Growth, Top Companies, Trends, Demand and Forecast to 2026 - Packaging News 24

Read More...

Stem Cell Therapy Market Opportunity Analysis and Industry Forecast up to 2017 2025 – Jewish Life News

March 3rd, 2020 1:42 pm

TMRR, in its recent market report, suggests that the Stem Cell Therapy market report is set to exceed US$ xx Mn/Bn by 2029. The report finds that the Stem Cell Therapy market registered ~US$ xx Mn/Bn in 2018 and is spectated to grow at a healthy CAGR over the foreseeable period.

The Stem Cell Therapy market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the Stem Cell Therapy market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses. In addition, the Stem Cell Therapy market study provides reliable and authentic projections regarding the technical jargon.

In this Stem Cell Therapy market study, the following years are considered to project the market footprint:

The content of the Stem Cell Therapy market report includes the following insights:

Request For Discount On This Report @ https://www.tmrresearch.com/sample/sample?flag=D&rep_id=1787&source=atm

On the basis of solution, the global Stem Cell Therapy market report covers the following solutions:

Key Trends

The key factors influencing the growth of the global stem cell therapy market are increasing funds in the development of new stem lines, the advent of advanced genomic procedures used in stem cell analysis, and greater emphasis on human embryonic stem cells. As the traditional organ transplantations are associated with limitations such as infection, rejection, and immunosuppression along with high reliance on organ donors, the demand for stem cell therapy is likely to soar. The growing deployment of stem cells in the treatment of wounds and damaged skin, scarring, and grafts is another prominent catalyst of the market.

On the contrary, inadequate infrastructural facilities coupled with ethical issues related to embryonic stem cells might impede the growth of the market. However, the ongoing research for the manipulation of stem cells from cord blood cells, bone marrow, and skin for the treatment of ailments including cardiovascular and diabetes will open up new doors for the advancement of the market.

Global Stem Cell Therapy Market: Market Potential

A number of new studies, research projects, and development of novel therapies have come forth in the global market for stem cell therapy. Several of these treatments are in the pipeline, while many others have received approvals by regulatory bodies.

In March 2017, Belgian biotech company TiGenix announced that its cardiac stem cell therapy, AlloCSC-01 has successfully reached its phase I/II with positive results. Subsequently, it has been approved by the U.S. FDA. If this therapy is well- received by the market, nearly 1.9 million AMI patients could be treated through this stem cell therapy.

Another significant development is the granting of a patent to Israel-based Kadimastem Ltd. for its novel stem-cell based technology to be used in the treatment of multiple sclerosis (MS) and other similar conditions of the nervous system. The companys technology used for producing supporting cells in the central nervous system, taken from human stem cells such as myelin-producing cells is also covered in the patent.

Global Stem Cell Therapy Market: Regional Outlook

The global market for stem cell therapy can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America emerged as the leading regional market, triggered by the rising incidence of chronic health conditions and government support. Europe also displays significant growth potential, as the benefits of this therapy are increasingly acknowledged.

Asia Pacific is slated for maximum growth, thanks to the massive patient pool, bulk of investments in stem cell therapy projects, and the increasing recognition of growth opportunities in countries such as China, Japan, and India by the leading market players.

Global Stem Cell Therapy Market: Competitive Analysis

Several firms are adopting strategies such as mergers and acquisitions, collaborations, and partnerships, apart from product development with a view to attain a strong foothold in the global market for stem cell therapy.

Some of the major companies operating in the global market for stem cell therapy are RTI Surgical, Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., NuVasive, Inc., Pharmicell Co., Ltd., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Holostem Terapie Avanzate S.r.l.

Request Sample Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1787&source=atm

The Stem Cell Therapy market study answers critical questions including:

All the players running in the global Stem Cell Therapy market are elaborated thoroughly in the Stem Cell Therapy market report on the basis of R&D developments, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines, legal policies, and comparative analysis between the leading and emerging Stem Cell Therapy market players.

Customize This Report @ https://www.tmrresearch.com/sample/sample?flag=CR&rep_id=1787&source=atm

Why choose TMRR?

Continued here:
Stem Cell Therapy Market Opportunity Analysis and Industry Forecast up to 2017 2025 - Jewish Life News

Read More...

Induced Pluripotent Stem Cells Created from Fat Cells …

March 3rd, 2020 1:41 pm

The standard way to make induced pluripotent stem (iPS) cells for medical research is to scrape skin cells and mix up their internal clocks, coaxing them back into pluripotency over a matter of weeks. But now researchers at the Stanford University School of Medicine have turned their attention to another cell type in abundant supply: fat cells. The team of cardiologists and plastic surgeons found adipose fat cells to be much more efficient than skin cells at turning back into stem cells.

The potential of iPS cells to help treat everything from damaged heart tissue to Parkinson's disease, has prompted intensive research that has looked into the use of skin fibroblast cells as an alternative to controversial embryonic stem cells. Skin cells, however, take a few weeks to be cultured into pluripotencya process that also often requires exposing the cells to mouse stem cells, called feeder cells, to nourish and guide the transformation.

"We thought, why not use a different cell typeand we can easily get access to fat," says Joseph Wu, a co-author of a study on this process and assistant professor of medicine at Stanford. Fat also "turns out to be a readily available, great natural resource," says Michael Longaker, a professor of plastic surgery at Stanford. He and Wu point out that more than a third of Americans are considered obese and even young, healthy patients would have ample fat to harvest for iPS cell culturing. Each liter of fat promises hundreds of millions of potential cells, Longaker estimates.

Other stem cells in the body, such as liver and stomach cells, have been examined for their ability to culture usable iPS cells. Fat stem cells, however, seem especially primed for the job, as they are capable of turning into fat, heart, bone or muscle tissue. "We know that these fat cells are multipotent, which should [make it] easier to reprogram them," Wu says.

Indeed, they were: According to the team's findings, adipose stem cells can be turned into iPS cells twice as quickly as fibroblast skin cells and with 20 times the efficiency. The process can begin immediately after the fat is harvestedvia liposuctionand cells are ready to culture within the same day.

The results were published online today in Proceedings of the National Academy of Sciences.

Wu and Longaker, both clinical practitioners, are always looking for methods that will present "one less hurdle to worry about," Longaker says. Being able to skip the mouse feeder cell step necessary with skin cells, along with the shortened culturing period, may make the new method more palatable to the U.S. Food and Drug Administration (FDA), which must approve such treatments for human use and prefers methods that reduce opportunities for contamination.

Wu, Longaker and their team still have many questions to answer before fat cells could become the latest industry iPS cell standard. They need to find out how much differentiation these cells require before they become helpful in specific areas of the body. "How much do you have to coach them in the dish before you put them back in the patient before they become heart muscles, say?" asks Longaker.

The ultimate safety of the cells, especially regarding their potential to spark cancer, will also need to be examined in more detail, notes Yasuhiro Ikeda, an assistant professor of molecular medicine at the Mayo Clinic's College of Medicine, in Rochester, Minn., who wasn't involved in the work. "It will be necessary to characterize the cells in more detailfor their tumorigenicity upon transplantation," he wrote in an email.

Wu and Longaker's research thus far has taken a fairly broad swipe at reprogramming adipose fat stem cells, so the team hopes to refine the process to target only the most efficient candidates. "If these are a so-called chicken soup of [cell] population, we dont know if it's one type of cell or five," Longaker says. "We would like to identify which sub-population is most easily reprogrammableand reprogram it in a way the FDA would approve of."

Other researchers in the field will be watching to see what further tests might reveal about the practicality of using fat cells instead of skin cells for iPS research. "This is definitely a promising new technology for iPS, particularly translating this technology into the clinic in the future," Ikeda notes.

Here is the original post:
Induced Pluripotent Stem Cells Created from Fat Cells ...

Read More...

Stem Cells from Fat vs. Bone Marrow – Best Sources for …

March 3rd, 2020 1:41 pm

Stromal vascular fraction was dramatically better than bone marrow concentrate in its ability to differentiate into cartilage.Two other important features were also well documented in this study. SVF created significantly more colony forming units than BMC, another significant predictor of healing response. Perhaps most importantly, SVF was dramatically better than BMC in its ability to differentiate into cartilage.

Second, a study by Han Chao et al has also demonstrated that fat derived stem cells also have a higher proliferation potential for neural tissue and are a better source for not only cartilage regeneration but also for nervous system regeneration.

The studies gave a very comprehensive look at comparing BMC and SVF in the ability to repair cartilage damage in a same procedure protocol. Every significant measurement comparing bone marrow to adipose tissue for stem cell harvesting demonstrated that adipose derived stem cells provided better cell content and superior ability to differentiate into cartilage than bone marrow. Our extensive clinical experience with the procedure for Colorado patients suffering from pain in the knees, other joints, soft tissue, and a wide range of back problems clearly demonstrates the same.

Using the most effective combination of autologous stem cell sources is one of several criteria to identify a legitimate stem cell clinic. Other important characteristics we recommend paying attention to when choosing a stem cell clinic, include the presence of a physician who owns and operates the clinic, X-ray guided injections administered by a trained injection specialist, and a clinic that takes time to discuss your questions. A review of your imaging and clinical data is needed in order to determine if stem cell therapy is right for you.

*Individual patient results may vary. Contact us today to find out if stem cell therapy may be able to help you.

See original here:
Stem Cells from Fat vs. Bone Marrow - Best Sources for ...

Read More...

MAX BioPharma Announces Key Update to its Liver Fibrosis Program Showing Efficacy of an Oxysterol Lead Drug Candidate in Inhibiting NASH in a…

March 3rd, 2020 1:41 pm

MAX BioPharma is Pursuing Strategic Partnerships and Series A Financing

LOS ANGELES, March 3, 2020 /PRNewswire/ --MAX BioPharma, Inc. (www.maxbiopharma.com) recently published an article describing its anti-tumorigenic oxysterol lead compound, Oxy210, in the peer-reviewed journal, Cells. (https://www.mdpi.com/2073-4409/8/10/1297/pdf). Oxy210 is derived from the Company's Oxysterol Therapeutics platform of proprietary oxysterols. Oxy210 was shown to inhibit two key cellular pathways, Hedgehog and transforming growth factor beta (TGFb), which play important roles not only in cancer but also in driving pathologic fibrosis in a number of organs including liver, lung and kidney. Oxy210 has unique mechanisms of action compared to other Hedgehog and TGFb signaling inhibitors that are commercially available or under clinical development. This new drug candidate is orally bioavailable, has favorable pharmacokinetic and safety profiles, is scalable, and was found to inhibit activation and pro-fibrotic activities of human liver stellate cells that drive fibrosis.

In a recent 16-week study conducted at UCLA under the direction of Drs. Jake Lusis and Simon Hui, Oxy210 was found to significantly inhibit development of fibrosis in a humanized mouse model of non-alcoholic steatohepatitis (NASH) that involves progressive inflammation, fat deposition and fibrosis in the livers of these mice. The inhibition of fibrosis involved inhibited expression of TGFb, NLRP3 inflammasome, and inflammatory cytokines: interleukin-6 (IL-6), tumor necrosis alpha (TNF-a), and monocyte chemotactic protein 1 (MCP-1) in the liver and plasma of mice that consumed Oxy210 incorporated in their food. Moreover, Oxy210 inhibited lipid deposition, including total cholesterol, unesterified cholesterol, cholesterol ester, and phospholipids in the livers of the hyperlipidemic mice.

"There is an urgent need for therapies to treat fatty liver disease, and I find the results of our studies with MAX BioPharma quite exciting," states Dr. Lusis, Principal Investigator and Professor of Medicine, Human Genetics, Microbiology, Immunology & Molecular Geneticsat UCLA.

"Our humanized hyperlipidemia mouse model of NASH reflects the natural history of non-alcoholic fatty liver disease (NAFLD) progression in humans and reproduces the salient features of human NASH. Attenuation of hepatic fibrosis and inflammation by Oxy210 suggest that it could be a promising therapeutic for human NASH," explains Dr. Hui, Project Scientist and Co-Principal Investigator at UCLA.

"Evidence that the Hedgehog-TGFb inhibitor, Oxy210, improves liver inflammation and fibrosis in the mouse model of NASH is encouraging given growing evidence that these signaling pathways critically control liver repair and are dysregulated in patients with NASH, cirrhosis and primary liver cancer," states Dr. Anna Mae Diehl, Florence McAlister Distinguished Professor of Medicine at Duke University.

MAX Biopharma is currently optimizing oral dosing with Oxy210 and performing pre-clinical studies required by the FDA for clinical development and commercialization, and is seeking strategic partnerships with biotechnology and pharmaceutical companies that have the expertise and resources to further the development of oxysterols towards FDA approval and commercialization. In addition, MAX BioPharma is in the process of raising a series A financing round to support the advancement of its therapeutic development programs. "We are very excited and hopeful that our efforts will result in an effective and safe therapy for NASH that will significantly improve the lives of those affected by this currently incurable disease" says Dr. Farhad Parhami, Founder, President and CEO of MAX BioPharma.

About MAX BioPharma, Inc.

MAX BioPharma is a privately-held preclinical stage California-based biopharmaceutical company developing novel small molecule lipids as drug candidates for intervention in debilitating and fatal human diseases. The company will be a leader in a new field of Oxysterol Therapeutics by leveraging a robust and growing intellectual property portfolio that will lead to treatments for numerous indications. MAX BioPharma's first success based on small molecule lipids has contributed to the discovery of novel osteogenic oxysterol compounds that target multipotent mesenchymal cells, including mesenchymal stem cells, to induce the formation of bone-forming osteoblasts and bone. The company is translating this technology into the next generation of therapeutic agents for stimulation of bone formation, locally and systemically, in indications such as spinal fusion, non-union fractures, and osteoporosis. MAX BioPharma is also pursuing the development of small molecule oxysterols that function as anti-tumorigenic Hedgehog and TGFb pathway antagonists that will be more effective than currently known antagonists in treating a variety of cancers, including lung and pancreatic cancer, and hematologic malignancies, as well as fibrotic diseases of liver, lung, and kidney among others. For more information please visit us at http://www.maxbiopharma.com

Media Contact: Farhad Parhamifparhami@maxbiopharma.com

View original content:http://www.prnewswire.com/news-releases/max-biopharma-announces-key-update-to-its-liver-fibrosis-program-showing-efficacy-of-an-oxysterol-lead-drug-candidate-in-inhibiting-nash-in-a-humanized-mouse-model-301015161.html

SOURCE MAX BioPharma

See the article here:
MAX BioPharma Announces Key Update to its Liver Fibrosis Program Showing Efficacy of an Oxysterol Lead Drug Candidate in Inhibiting NASH in a...

Read More...

Uveitis Treatment Market Research Report: Analysis by SWOT, Capacity, Production and Value Future Forecast To 2025 – News Times

March 2nd, 2020 2:50 am

Global Uveitis Treatment Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2019-2025Increasing demand for advanced healthcare products and rising number of patients affected by Cataract and other eye related diseases are some factors driving the growth of Global Uveitis Treatment Market.

Global Uveitis Treatment Market is valued around USD 475.7 Million in 2018 and expected to reach USD 724.8 Million by 2025 with the CAGR of 6.2% over the forecast period.

Uveitis disease directly affects the eyes and the most common symptoms of uveitis are eye inflammation and swelling that can destroy eye tissues. Whether its humans eye or any animals, uveitis affects everyone and can lead to poor vision or blindness. It is named as uveitis because mostly the swelling affects the part of eye which called uvea. Basically eye is made of several layers and uvea is the middle layer, its between white part of eye and the inner layers of eye which called the sclera.

Uvea has three important structures the iris, the ciliary body and the choroid. The Iris is colored circle at the front of eye, the ciliary body helps to focus eye lens and makes fluid that nourishes inside of eye and the choroid is group of blood vessels which gives the nutritions to the retina it needs. People who are suffering from AIDS, Ankylosing spondylitis, Behcets disease, CMV retinitis, Herpes zoster infection, Histoplasmosis, Kawasaki disease, Multiple sclerosis, Psoriasis, Reactive arthritis, Rheumatoid arthritis etc. have greater risk of having uveitis than normal people.

Global uveitis treatment market is segmented on the basis of type, application and region & country level. On the basis of type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis and Panuveitis. On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and drug stores.

The regions covered in this Uveitis Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Uveitis Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global Uveitis Treatment Market report covers prominent players like Allergan, Bausch & Lomb, Novartis, AbbVie, Santen Pharmaceutical, Eyegate Pharmaceuticals, Alimera Sciences.

Get Discount:https://brandessenceresearch.com/DiscountOffers/RequestOffer/554

Market Dynamics-

Advanced technological requirements in healthcare, increasing disposable income and high expenditure on healthcare are some of the factors driving the market of uveitis treatment. Uveitis can affect eyes through dirt, pollution, viral, fungal, bacterial infections, etc. and uveitis cause cataract. Cataract is responsible for worlds around 51% of blindness which is about 20 million people. Smokers have more risk of uveitis and of blindness. There are around 1.2 million people who are smokers, there is a huge number of smokers some of them are suffering from diseases and 80% of them are from low and middle income countries. Thus, all these factors are expected to foster the growth of this market.

However, high cost of treatment and lack of skilled professionals can restrain the market growth. In spite of this, technological advancement, increasing numbers of hospitals, diagnostic centers, online treatments are some factors which can provide various opportunities for the further growth of the market.

North America is expected to dominate the Global Uveitis Treatment owing to the high investment in this field. In addition, research and development by leading players to develop new innovative products in this region is also fostering the market growth. For example, Allergan expanded REFRESH portfolio with new REFRESH, RELIEVA Lubricant Eye Drop Product Line. The annual direct medical cost in the US is estimated to USD 117 million. Uveitis accounts 10% of blindness globally. 60%-80% uveitis patient occur in patient in third to sixth decade of life with an age of occurrence of 35. The prevalence of uveitis is estimated 17 per 100000 in Europe which is comparable to the US. Uveitis is one of the major reasons for the birth of cataract and it accounts for 30%50% of blindness in most Asian countries.

By Product Type:

By Application:

Get Full Report at:https://brandessenceresearch.com/healthcare/uveitis-treatment-market-size

Read the original post:
Uveitis Treatment Market Research Report: Analysis by SWOT, Capacity, Production and Value Future Forecast To 2025 - News Times

Read More...

RNIB Scotland report highlights problems faced by patients with severe sight and blindness – AOP

March 2nd, 2020 2:50 am

The charity calls for Scottish health boards to ensure that accessible information policies are implemented

Blind and partially sighted people are still struggling to receive healthcare information in a format that is accessible to them, according to new research published by the Royal National Institute of Blind People (RNIB) Scotland.

The Communications failure report released by the charity last week (17 February) highlights that patient confidentiality is breached when people have to rely on carers, relatives and friends to read appointment letters, medication and test results.

Author of the report, Laura Jones warned: This can put patients at risk of missing treatment as well as being confused or misinformed about their healthcare needs. The NHS, itself, puts great emphasis on the cost, in money and time, of missed appointments to over-burdened clinics, so giving patients accessible information makes sense.

The report was launched by MSP Stuart McMillan and calls for the countrys 14 health boards to ensure that accessible information policies are implemented. It also encourages awareness training for all healthcare staff.

Ms Jones highlighted that it has been almost 10 years since The Patients Rights (Scotland) Act 2011 was introduced. The charter states You have the right to be given information about your care and treatment in a format or language that meets your needs.

The report found that some patients had not been informed that they could request information in alternative formats, while others lacked the confidence to request information in accessible formats as they did not want to be considered a burden or difficult.

While the report notes that increasingly healthcare information is provided online, people with disabilities show low levels of digital uptake.

Follow this link:
RNIB Scotland report highlights problems faced by patients with severe sight and blindness - AOP

Read More...

Blind pug and his seeing-eye chihuahua in need of forever home – FOX 29 News Philadelphia

March 2nd, 2020 2:50 am

GREELEY, Colo. - Augie, a 12-year-old pug has never seen his best friend Pepe, achihuahua, but that doesnt matter. The two have been inseparable for years.

The duo arrived at the Colorado Pug Rescue after their owner was diagnosed with a terminal illness.

Augie has been blind most of his life, according to foster parent Cyndi Trimber. They sleep together, she said. Its really sweet. Its really sweet that they kind of depend on each other like that.

Unfortunately, the pugs emotional support pal couldnt prepare him for what would happen next. Augies blindness was so bad, he had to have both of his eyes removed a couple of weeks ago. Plus, some major dental surgery.

The group was billed $3100 for the operations, emergency money they didnt expect to spend, given it helps more than 100 pugs throughout the year.

Trimber said, I went to pick him up and Im like, Holy! Its a foster group. You know? Where are we going to get that kind of money?

The Colorado Pug Rescue is hoping some kind folks will help with donations and perhaps provide these best friends with a forever home.

I just want them to have the best possible life they can have, Trimber explained.

Learn more about how to help Augie and Pepe here.

Follow this link:
Blind pug and his seeing-eye chihuahua in need of forever home - FOX 29 News Philadelphia

Read More...

Harikrishnan KS’ graduating collection makes a noise at the London College of Fashion – Ahmedabad Mirror

March 2nd, 2020 2:50 am

HE has become a global sensation among the fashion press, even though he hasnt debuted professionally yet. Harikrishnan KS, 26, just presented his graduating collection at the UKs cutting-edge London College of Fashion and received both favourable reviews as well as trolling for his unusual silhouettes (musician MC Hammer tweeted hes a fan). The infl atable latex trousers with impossible proportions have been featured on the BBC and in magazines like the British Vogue, i-D and Dazed, to name a few. Hari, as he calls himself, hails from Kerala and studied at NIFT Bangalore, before he went on to assist the talented Woolmark Prize winner Suket Dhir in New Delhi. People are going nuts about him, his collection was really avant-garde, Dhir says proudly. Hari, who suff ers from colour blindness, tells your diarist, I was playing with my dog when I decided to see myself through his eyes. Its almost like seeing the world through a fi sh-eye lens. He adds he has no interest in selling his infl atable pants, but has received a couple of orders for music video costumes. Haris fashion heroes are French graphic designer and illustrator Jean-Paul Goude, and Dhir, of course.

Read more here:
Harikrishnan KS' graduating collection makes a noise at the London College of Fashion - Ahmedabad Mirror

Read More...

Harder to Rx but Easy on the Eyes, These 9 Styles Make the Lenses the Main Attraction – InvisionMag

March 2nd, 2020 2:50 am

Part of the newly introduced Titan Accent Shades Collection, the 8174_7530 brings the hinge-free, three-piece mount frames of Titan Minimal Art together with the shapes of the brands Accent Shades.

(518) 272-5500, silhouette.com

$420

Offering a generous nod to the Palme dOr, the highest award given at the Cannes Film Festival, the SCHD48S features a palm-leaf pattern on each lens and is part of the Palm Collection, naturally.

(800) 423-3023, derigo.us

$750

Blings the thing for this MK1058B, putting Swarovski crystals to work on triple-gradient lenses in front of jewelry-chain inspired temples.

(800) 422-2020, my.luxottica.com

$209

Inspired by the Fendi Couture Fall/Winter 2019-20 Collection, the FF 0404/G/S celebrates its iconic logo on an oversized sun with metal-studded temples.

(800) 631-1188, mysafilo.com

$365

A star is born with the GG0666S, a cat-eye shape that makes an impact with Guccis cant miss logo and star-shaped rivets.

kering.com

$725

Direct sunlight brings the Lovelace in gunpowder/18k gold with yellow gradient Stardust lenses to life with speckled lenses by Dalloz Creations.

leisure-society.com

$625

Featuring a mask design and metal micro studs, the MCM694S is defined by double-lens layering and a visible-through-the-temples wire core.

(800) 645-1300, marchon.com

$435

Featured in the Berluti Spring-Summer 2020 Collection, the BL40007U in black acetate features smoke lenses with silver-mirror Scritto print.

thelios.com

$510

The GLCO x Malbon Golf collaboration includes the Hampton, which reveals a Malbon breath logo when and only when the lenses fog up.

garrettleight.com

$340

Read the rest here:
Harder to Rx but Easy on the Eyes, These 9 Styles Make the Lenses the Main Attraction - InvisionMag

Read More...

"You would have lost vision in both eyes." Jaime Cerreta’s eye health scare – AZFamily

March 2nd, 2020 2:48 am

PHOENIX (3TV/CBS 5) -- "You would have lost vision in both eyes, complete vision loss," that's what Ophthalmologist Dr. Ramin Schadlu told me around 8 p.m. on a Wednesday night.

I looked at my father--who had come with my mother to my emergency appointment at Arizona Retina and Vitreous Consultants. I was beyond scared. The doctor called me "stoic". The truth is, I didn't really believe what he was saying and was slowly swallowing fear.

[WATCH: Jaime Cerreta talks about a health scare that could have blinded her]

There were no major symptoms. Sure, I had been seeing floaters for a few weeks. And the floaters were new. But doesn't everyone see floaters?

I would learn how very important it is to go to the doctor as soon as you see any change in your vision.

I visited my doctor, Dr. Justin Macklin, at LensCrafters at 3 in the afternoon that day. It was during my Local Love that morning, that I noticed a black spot in my vision and I called and asked to come in. After a careful examination, Dr. Macklin leaned back from his equipment and said, "I have some bad news".

That's when I would go immediately for laser treatment. "What I found in your eye was a retinal tear with some fluid around it. When I looked at the other eye, it turned out that you had a confined retinal detachment in the other eye as well," said Schadlu.

Dr. Schadlu told me to go back to the waiting room and he would call me back in for laser treatment. I was in some sort of emergency eye facility at Arizona Retina and Vitreous Consultants. It was way past 6 p.m., yet there was a full waiting room and no one seemed in a hurry to get home. When I asked, the staff told me-- we stay until the last patient's been treated. This retinal injury-- so dire and so important that the staff works on call as well.

That night we would treat the left eye--with the tear--at 8:30 p.m. that night. I would go back the next day to treat my right eye.

So... how did this happen? You can blame my bad eyesight.

"You get it earlier because your eye is longer. A -10 is a longer eye and as a longer eye--it doesn't take much shrinking of the gel to cause tears," said Schadlu.

It's common as we age as the retina thins and could also be genetic.

But Dr. Shadlu says it's also just bad luck. So we rely on that laser to save my vision. The laser treatment takes maybe 20 minutes. It doesn't hurt but is uncomfortable.

I found myself whimpering through the procedure. It's a bright light that I could feel in my optic nerve. That bright light is "spot welding" my retina back in place. So I am grateful for the weird, intense feeling that is ultimately saving my vision. I would spend the next several days away from my phone, away from work and in a strange mental space ping ponging between gratitude and "what if's."

But I learned one thing that I will forever preach.. if you see floaters, flashes of light, or darkness--- get to the doctor within 24 hours. I still have that dark spot in my vision. I have some floaters that look like pepper falling. And sometimes the treated spot "sparkles" when I move from outside to inside.

I am so mad at myself for not going to the doctor sooner. Had I just done that, maybe that black spot wouldn't be there. It is distracting and Dr. Schadlu says my mind will learn to ignore it. But it's a reminder to me of what could have been and that I ignored my health.

I should have gone sooner. Please learn from my mistake. I promise I will take my health more seriously in the future.

Thank you to my friends, family and colleagues who showed me so much love during this journey. Thank you to Dr. Macklin, Dr. Schadlu, Dr. Anita Prasad, and their incredible staff.

Thank you TO YOU for your love and prayers. I am so grateful for the people who watch me on TV and allow me into their lives.

Go here to see the original:
"You would have lost vision in both eyes." Jaime Cerreta's eye health scare - AZFamily

Read More...

What to do if the eyes no longer have it – Stuff.co.nz

March 2nd, 2020 2:48 am

Hands up if you've done any of the following recently: moved the candle on a restaurant table closer so you can read the menu; enlarged the text on your phone to read your messages; or given up reading at night because your eyes are just too tired by the end of the day.

You're not alone. After a lifetime without any vision issues it can be a little daunting to discover your eyesight is not as sharp as it used to be. But Specsavers optometrist Ayah Hadi says if you've had more than 40 birthdays, it's reassuring to know you're right on schedule when it comes to needing a little more help to focus and read the fine print.

"It's nothing to worry about, it's just one of those natural processes that happen as we age," she says. "Every day at work I speak with people who describe a whole spectrum of symptoms from taking photos of contracts then magnifying them on their phone so they can read them, to holding their phone further and further away from their face until they have run out of enough arm-length to focus.

"It's a process, and sometimes it takes people a while to accept that things are changing, but it's a good idea to have a chat with an optometrist to figure out what can be done. At the end of the day it's about making sure you can see and continue to do everything you like and need to do in life."

SPECSAVERS/SUPPLIED

Specsavers optometrist Ayah Hadi says if you're over 40 then you might need some help with your eyesight.

These age-related changes to our eyes are known as presbyopia. Our eyes have a flexible, crystalline lens that sits behind the coloured iris, which allows us to see clearly up close and far away. But as we get older, this lens naturally starts to lose its elasticity which affects our ability to focus. Objects close to our eyes become blurry and the point of closest focus moves further away from our eyes.

Hadi says during an eye test, your Specsavers optometrist will figure out what kind of prescription lenses will work best for your eyes and your lifestyle. That could be a pair of reading glasses that makes close work easier, or progressive lenses which combine close, midrange and distance vision into one pair of glasses.

"Alternatively, if you're active or do a lot of sport, you might opt for progressive contact lenses," she says. They're also a possibility if you don't like the idea of wearing glasses, or just want another option.

SPECSAVERS/SUPPLIED

Specsavers optometrist Ayah Hadi, says their complete eye health check includes OCT - an advanced 3D scan of the interior of the eye.

An appointment with a Specsavers optometrist isn't just about finding the right prescription. It's also a complete eye health check that includes OCT - an advanced 3D scan of the interior of the eye which can pick up conditions which aren't natural age-related changes. Early detection of these conditions is key to preventing permanent vision loss.

"It's important to have an eye test at least every two years", says Hadi. "That way we can make sure your eyes are perfectly healthy and the changes you are noticing are just age-related."

With Specsavers stores open seven days a week and offering a variety of discounts, Hadi says quality eye care is very accessible, and she loves seeing the difference a visit can make for people.

"For me it's about that 'wow' moment when someone puts on a prescription lens and says, 'Ahh, I can see!'. It's like pulling out a magic trick."

Book your Specsavers eye test today.

Here is the original post:
What to do if the eyes no longer have it - Stuff.co.nz

Read More...

Oregon Lions Foundation helps kids get the vision treatment they need – Coos Bay World

March 2nd, 2020 2:48 am

SALEM It takes 15 seconds to check a childs vision, to determine if the child needs glasses or further eye care.

That 15 seconds can change a childs life. Without the screening, a child with vision problems will likely struggle in school, possibly becoming one of the nearly 20 percent of high school students across Oregon who dont graduate. In fact, a student who cant read at grade level by the end of third grade is 13 times less likely to graduate from high school.

With the screening, the child has a much greater chance to get the vision help that he or she needs, which can lead to success in school. That can lead the child beyond high school graduation to advanced degrees and successful careers, and it can set the child up to become one of your communitys future leaders.

The Oregon Lions Sight & Hearing Foundation can do this screening in 15 seconds with vision-testing equipment. In fact, the Foundation and its partners can screen an elementary school with 450 students in two hours. But the foundation needs help to screen every student across the state.

The Oregon Legislature has mandated that every elementary school student through age 7 across the state have a documented vision screening. The Legislature has incorporated funds within the Oregon Department of Education budget to cover screening for students up to their senior year in high school, with funding priority given to students pre-kindergarten through third grade.

The Oregon Department of Education has $2 million per year for the 2019-2020 and 2020-21 fiscal years for the screenings. The funds cover almost half of Oregons students through 12th grade, which means the Foundation needs further support from the communities it serves across Oregon.

Colt Gill, ODE director, participated in a recent vision screening in Salem and noted, Based on the results, some of the students will be heading to the eye doctor. That will set them on a path to learning and being successful in school so I really appreciate the work.

"Support for vision screening of Oregon students is basically joining the alliance of those working to improve our high school graduation rate here in Oregon, said Doug Thompson, executive director of the foundation. This is our future workforce so let's equip them now with the tools needed to be successful in life."

The recent Foundation screening at Liberty Elementary School in Salem showcased what the Foundation can do for elementary school students. Each class took their turns getting screened, with five Health Career students from Sprague High School using the hand-held screening machines to check the kids vision. Members of the South Salem Lions Club directed traffic, which moved quickly between the 15-second screenings.

The Foundation will report the results back to the Salem-Keizer school district which will work with the parents to get eye care to the students who need it.

Lynn Oehler, lead nurse for the district, said the machines can detect with 13 measures up to 8 conditions in each eye.

We have a pretty high rate of referrals for further care, but its mainly for conditions like astigmatism and other conditions that can be easily corrected, Oehler said. When we catch these conditions at a younger age, it absolutely helps the students learning process.

And its so much more efficient with the new technology, said Eric Richards, director of student services for the Salem-Keizer School District. Prior to the handheld machines, the foundation used eye charts, which dont allow for testing of nearly as many conditions.

This is a wonderful service and an important partnership with the Foundation, Richards said.

Brad King, one of the Foundations screening coordinators, said the Foundation is planning to screen an entire Portland-area high school with more than 2,800 students. He anticipated it will take an entire day but will be worth it to make sure any students with vision problems are identified.

With local financial support and partnership, the Oregon Lions Sight & Hearing Foundation can reach every student in the state. The Foundation is a 501c3 nonprofit, with a four-star ranking from Charity Navigator, and due to all administrative expenses being covered by its own long term investment fund every dollar raised by the organization directly supports its sight and hearing services.

OLSHF maintains a yearly review with the Better Business Bureau. The organization meets all 20 Standards for Charity Accountability and is a BBB Accredited Charity.

The Foundation can screen a child for $3.20, which is about 10 percent of the cost in an optometric office. The Department of Educations budget for screenings is enough to cover more than 281,000 students per year, kindergarten through 12th grade, not enough to cover all of Oregons 582,000 students.

Your support of the screenings would be used to offset any costs not covered by the state for screenings in your community, Thompson said. It would also assist with the costs associated with helping the students referred as needing a follow-up exam and new eyeglasses, to receive them.

Read the original:
Oregon Lions Foundation helps kids get the vision treatment they need - Coos Bay World

Read More...

Page 656«..1020..655656657658..670680..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick